Open Access

A comprehensive curated resource for follicle stimulating hormone signaling

  • Deepthi Telikicherla1, 2,
  • Aditi Ambekar3,
  • Shyam Mohan Palapetta1, 4,
  • Sutopa B Dwivedi1, 5,
  • Rajesh Raju1, 2,
  • Jyoti Sharma1, 6,
  • TS Keshava Prasad1, 4, 6,
  • YL Ramachandra2,
  • S Sujatha Mohan1, 2, 7,
  • Jagadeesha Maharudraiah1, 6, 8,
  • Srabani Mukherjee3 and
  • Akhilesh Pandey9, 10, 11, 12Email author
BMC Research Notes20114:408

DOI: 10.1186/1756-0500-4-408

Received: 18 April 2011

Accepted: 13 October 2011

Published: 13 October 2011

Abstract

Background

Follicle stimulating hormone (FSH) is an important hormone responsible for growth, maturation and function of the human reproductive system. FSH regulates the synthesis of steroid hormones such as estrogen and progesterone, proliferation and maturation of follicles in the ovary and spermatogenesis in the testes. FSH is a glycoprotein heterodimer that binds and acts through the FSH receptor, a G-protein coupled receptor. Although online pathway repositories provide information about G-protein coupled receptor mediated signal transduction, the signaling events initiated specifically by FSH are not cataloged in any public database in a detailed fashion.

Findings

We performed comprehensive curation of the published literature to identify the components of FSH signaling pathway and the molecular interactions that occur upon FSH receptor activation. Our effort yielded 64 reactions comprising 35 enzyme-substrate reactions, 11 molecular association events, 11 activation events and 7 protein translocation events that occur in response to FSH receptor activation. We also cataloged 265 genes, which were differentially expressed upon FSH stimulation in normal human reproductive tissues.

Conclusions

We anticipate that the information provided in this resource will provide better insights into the physiological role of FSH in reproductive biology, its signaling mediators and aid in further research in this area. The curated FSH pathway data is freely available through NetPath (http://www.netpath.org), a pathway resource developed previously by our group.

Background

Follicle stimulating hormone (FSH) is a glycoprotein hormone secreted by cells called gonadotrophs in the anterior pituitary gland. The major function of FSH is to promote and sustain the ovarian follicular growth in female [1] and spermatogenesis in male [2]. FSH stimulates the synthesis of its own receptor on the granulosa cells of the ovary [3] and in Sertoli cells [4] of the testes. Treatment with FSH also results in the expression of the luteinizing hormone (LH) receptor on granulosa cells [5]. FSH secretion is under the control of pulsatile GnRH release from hypothalamus. The production of estrogen, progesterone and inhibin from ovarian cells is, in turn, controlled by FSH. Estrogen and inhibin regulate FSH secretion through negative feedback on the pituitary [6]. All these dynamic changes in the hypothalamo-pituitary-ovarian axis are required for selection of the dominant follicle, ovulation and thus the menstrual cycle.

FSH is a member of glycoprotein hormone family, which also includes LH, human chorionic gonadotropin (hCG) and the thyroid stimulating hormone (TSH). These hormones are heterodimeric proteins comprised of a common α subunit and a unique β subunit that confers the biological specificity to each hormone. The receptors of these hormones belong to the G-protein coupled receptor (GPCR) superfamily, members of which contain seven transmembrane alpha helical domains [7].

Binding of FSH to its cognate receptor, FSH receptor (FSHR), triggers rapid activation of multiple signaling cascades. FSH action is primarily mediated via activation of the receptor associated heterodimeric G-proteins, which results in stimulation of adenylate cyclase activity and production of cyclic AMP (cAMP) [8]. Consequently, the cAMP-dependent protein kinase (PKA) is activated which in turn leads to phosphorylation of several transcription factors including cAMP responsive element binding protein (CREB), as well as chromatin remodeling through histone H3 modifications [9, 10]. Cyclic AMP/PKA also enhances the activity of p38 mitogen-activated protein kinase (p38MAPK), extracellular signal regulated-kinase (ERK) and phosphatidylinositol-3-kinase (PI3K), which can also be activated by PKA-independent manner [11]. These activated kinases further activate specific transcription factors, which regulate expression of FSH-target genes including aromatase [12], vascular endothelial growth factor VEGF [13], serum- and glucocorticoid-inducible kinase (SGK) [14] and steroidogenic acute regulatory protein (STAR) [15]. Early response genes induced by FSH include cyclin D2, the regulatory subunit of protein kinase A (RII-β) and SGK and the late response genes include cycloxygenase-2 (COX-2) and LH receptor (LHR) [16]. In addition, FSH activates the transcription factor hypoxia-inducible factor-1 (HIF-1) downstream of the PI3-kinase/AKT/Rheb/mTOR axis [17]. Apart from cAMP, FSH increases intracellular concentrations of other second messengers including calcium and inositol 1, 4, 5-triphosphate (IP3) [18, 19].

Although FSH signaling has been relatively well studied, there is a dearth of resources, which provide comprehensive information about the molecules involved in the FSH signaling pathway, the transcription factors activated by FSH and the genes whose expression is eventually regulated. Several online pathway databases including The Database of Cell Signaling (http://stke.sciencemag.org/cm/), KEGG Pathway Database (http://www.genome.jp/kegg/pathway.html), Pathway Interaction Database of the National Cancer Institute (http://pid.nci.nih.gov/) and INOH Pathway Database (http://www.inoh.org/) contain generic information about GPCR signaling. None of these resources provide information specific to FSH-induced signaling. Because of the importance of this pathway in human physiology and disease, we undertook a systematic effort to gather and curate the relevant information available in published literature to create a public resource of the signaling events triggered by FSH.

We have previously developed NetPath [20], a public resource of signaling pathways, with the initial set of annotated pathways focused on those important in immunology and cancer biology. As a next step, we set out to extend this list and generate additional signaling pathways that are relevant to a variety of human physiological processes. Here, we report the development of a pathway map consisting of individual biochemical events that are triggered by the activation of FSH receptor by FSH.

Pathway reactions and criteria for curation

FSH signaling pathway reactions have been curated in three categories-molecular associations, enzyme-substrate reactions and protein transport reactions. The curation of FSH pathway reactions were based on the following criteria: (i) reactions should be stimulated by FSH/FSHR system in vivo and compared to an unstimulated state; (ii) proteins involved in reactions should be from human system, however other mammalian proteins were annotated if they were not reported from human system; and, (iii) only experiments carried out in cell lines of mammalian origin were considered.

The molecular association reactions include both direct (binary association) and complex (multimeric association) protein-protein interactions stimulated by activated FSHR. The enzyme-substrate reactions induced by FSH were curated as direct (where the immediate upstream enzyme responsible is known) or induced (where the immediate upstream enzyme is not known) reactions. The protein sub-cellular translocation events induced by FSH were curated as transport reactions. In many studies, the authors investigate only the activation status of molecules under stimulation with the ligand. These reactions which cannot be categorized as either molecular associations or enzyme-substrate reactions were documented under a separate category called activation/inhibition reactions. Reactions in the FSH pathway were curated from literature dealing with studies carried out in mammalian host systems with the reactions reported in humans preferred over mouse, rat, bovine or other mammals.

Generation of a curated resource of FSH signaling

The articles relevant to FSH induced signal transduction events were retrieved from PubMed. From these research articles, we documented 11 molecular association events, 35 enzyme-substrate reactions, 11 activation events and 7 protein translocation events that occur upon FSH stimulation. The site of post-translational modifications were also documented and mapped to RefSeq whenever this information was available. FSH pathway reactions are available in NetPath at (http://www.netpath.org/pathways?path_id=NetPath_25) and will be periodically updated. Figure 1 provides an overview of FSH pathway page in NetPath.
https://static-content.springer.com/image/art%3A10.1186%2F1756-0500-4-408/MediaObjects/13104_2011_Article_1145_Fig1_HTML.jpg
Figure 1

An overview of the FSH pathway page in NetPath. The FSH pathway page in NetPath displays the statistics of data in the FSH pathway reactions including the number of proteins, protein-protein interactions, enzyme-substrate reactions, translocation events and differentially regulated genes in normal/primary human cells. The complete list of these reactions is accessible through the specific links provided for each reaction. Brief comments are provided for reactions curated under reactions such as PPI, enzyme-substrate reactions and transport. Each of these molecules is linked to NetPath molecule page which is further linked to Entrez gene, HPRD [30], OMIM [31] and Swiss-Prot [32] identifiers. A list of curators/reviewers is provided in the FSH pathway page with the details of the Pathway Authority. A 'comments' tab is provided in the pathway page to invite queries and suggestions from the community as a means to keep the pathway updated and as error-free as possible.

Visualization of FSH pathway

There have been efforts by other groups to catalog and represent reactions of signal transduction pathways [2123]. They have used Systems Biology Graphical Notation (SBGN) for representation of the pathways [24]. Therefore, we used CellDesigner Version 4.1 (http://www.celldesigner.org/) to generate the pathway map in the SBGN format (Figure 2). A high resolution image of the map is provided as Additional File 1. Apart from the protein components involved, small molecules like cAMP, IP3, DAG and Ca++ which play a major role in FSH signaling are also represented in the map. Many of the reactions in the current pathway map are derived from a single experiment and may be less reliable. Thus, we have also generated a slim version of the FSH pathway map by applying more stringent criteria (http://www.netpath.org/netslim/fsh_pathway.html). A detailed description of the NetSlim criteria is available at the same portal.
https://static-content.springer.com/image/art%3A10.1186%2F1756-0500-4-408/MediaObjects/13104_2011_Article_1145_Fig2_HTML.jpg
Figure 2

FSH pathway reaction map generated using CellDesigner. The reactions in the pathway resource were used to obtain a descriptive network of reactions using CellDesigner. The legend for the pathway map is provided in the box to the right. The reactions are broadly arranged according to the cellular component they occur in and are depicted here on the plasma membrane (yellow thick line at the top) and the nucleus (the rectangle with the blue border at the bottom) and the cytosol (the space between the yellow line and the blue rectangle). The small molecules such as cyclic AMP (cAMP), calcium (Ca++), inositol 3-phosphate (IP3) and diacylglycerol (DAG) which are important mediators of FSH signaling are also represented in the map.

Genes regulated by FSH

Apart from the molecular association, catalysis and translocation events, we included information regarding the genes that are differentially regulated by activated FSHR in normal human reproductive tissues. We documented 265 such genes whose expression levels changed in response to FSH administration. Out of these, 166 genes were upregulated and 99 were downregulated following FSH induction of human ovarian granulosa cells. Five of the eight articles which were curated were high-throughput mRNA expression profiling studies. The differential expression of some genes was also validated using RT-PCR in two of these studies. We included data only from studies carried out in normal human cells/tissues. A minimum fold change value of 2 and a p-value < 0.05 were taken as arbitrary cutoffs for inclusion into the resource. Data was not annotated from studies carried out in any disease setting. We also excluded studies where other hormones such as LH or hCG were used along with FSH for granulosa cell stimulation as there was ambiguity about the genes regulated by individual hormones. We have also documented several instances where specific transcription factors induced by FSH were shown to control the expression of differentially regulated genes.

Availability and data formats

The FSH pathway data is compatible with various standard data exchange formats including Proteomics Standards Initiative Molecular Interaction XML format (PSI MI) [25], a standard format for data representation in proteomics to facilitate data comparison, exchange and verification; BioPAX (http://www.biopax.org/) [26], a standard language that enables integration, exchange, visualization and analysis of biological pathway data and the Systems Biology Markup Language (SBML) (http://sbml.org/), a computer-readable format for representing models of biological processes [27]. This allows interoperability with other data analysis software tools such as Cytoscape, Visualization and layout services for BioPAX pathway models (VISIBIOweb) [28] or Chisio BioPAX Editor (ChiBE) [29]. The data for this pathway is freely downloadable from http://www.netpath.org/pathways?path_id=NetPath_25. The SBML format of the map given in Figure 2 is provided as Additional File 2.

Review by Pathway Authority

Although the information in this resource is curated from published literature in accordance with our curation strategy and had been subjected to various levels of internal review, we consider it necessary that an expert in this area is involved to ensure its accuracy and comprehensiveness. For this pathway, the data was reviewed by S.M, who is one of the co-authors, and is the designated Pathway Authority (http://www.netpath.org/pathway_authority?path_id=NetPath_25). We hope to continue this model for curation of pathways in the future where we involve experts on individual pathways as Pathway Authorities and include them as co-authors on descriptions of the corresponding pathways.

Conclusions

Studies of molecular events that result from activation of various receptors by their ligands are key to understanding various biological processes. Availability of such information serves as an invaluable tool for analyzing various kinds of high-throughput data obtained from gene/protein arrays as well as proteomic experiments. These analyses may include overlaying the high-throughput data onto known pathway reactions as well as perturbation analyses. We here describe the generation of a pathway map of the signaling events that are mediated by activated FSHR, through a systematic and detailed curation of the relevant published literature. This is aimed at providing a global and comprehensive view of the intracellular signaling events as well as the biological processes regulated by FSH. This would also enable researchers to perform various pathway as well as systems biology type of analyses on high-throughput data.

Declarations

Acknowledgements

We thank the Department of Biotechnology, Government of India for research support to the Institute of Bioinformatics. Deepthi Telikicherla is a recipient of a Senior Research Fellowship from Indian Council of Medical Research, Government of India. Shyam Mohan Palapetta, Rajesh Raju, Sutopa B. Dwivedi and Jyoti Sharma are recipients of a Senior Research Fellowship from the Council of Scientific and Industrial Research (CSIR), Government of India. Aditi Ambekar is a recipient of Junior Research Fellowship from the Board of Research in Nuclear Sciences, Department of Atomic Energy (DAE-BRNS), Government of India. T.S. Keshava Prasad is a recipient of a Young Investigator award from DBT.

Authors’ Affiliations

(1)
Institute of Bioinformatics, International Tech Park
(2)
Department of Biotechnology, Kuvempu University
(3)
Department of Molecular Endocrinology, National Institute for Research in Reproductive Health (ICMR)
(4)
Centre of Excellence in Bioinformatics, School of Life Sciences, Pondicherry University
(5)
Amrita School of Biotechnology, Amrita University
(6)
Manipal University
(7)
Laboratory for Immunogenomics, Research Unit for Immunoinformatics, RIKEN Research Center for Allergy and Immunology
(8)
RajaRajeshwari Medical College and Hospital
(9)
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine
(10)
Department of Biological Chemistry, Johns Hopkins University School of Medicine
(11)
Department of Pathology, Johns Hopkins University School of Medicine
(12)
Department of Oncology, Johns Hopkins University School of Medicine

References

  1. Hunzicker-Dunn M, Maizels ET: FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal. 2006, 18 (9): 1351-1359. 10.1016/j.cellsig.2006.02.011.PubMedPubMed CentralView Article
  2. Walker WH, Cheng J: FSH and testosterone signaling in Sertoli cells. Reproduction. 2005, 130: 15-28. 10.1530/rep.1.00358.PubMedView Article
  3. Minegishi T, Kishi H, Tano M, Kameda T, Hirakawa T, Miyamoto K: Control of FSH receptor mRNA expression in rat granulosa cells by 3',5'-cyclic adenosine monophosphate, activin, and follistatin. Mol Cell Endocrinol. 1999, 149 (1-2): 71-77. 10.1016/S0303-7207(98)00259-7.PubMedView Article
  4. Maguire SM, Tribley WA, Griswold MD: Follicle-stimulating hormone (FSH) regulates the expression of FSH receptor messenger ribonucleic acid in cultured Sertoli cells and in hypophysectomized rat testis. Biol Reprod. 1997, 56 (5): 1106-1111. 10.1095/biolreprod56.5.1106.PubMedView Article
  5. Lindeberg M, Carlstrom K, Ritvos O, Hovatta O: Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis. Hum Reprod. 2007, 22 (2): 401-406.PubMedView Article
  6. de Kretser DM, Phillips DJ: Mechanisms of protein feedback on gonadotropin secretion. J Reprod Immunol. 1998, 39: 1-12.PubMedView Article
  7. Salesse R, Remy JJ, Levin JM, Jallal B, Garnier J: Towards understanding the glycoprotein hormone receptors. Biochimie. 1991, 73 (1): 109-120. 10.1016/0300-9084(91)90083-D.PubMedView Article
  8. Conti M: Specificity of the cyclic adenosine 3',5'-monophosphate signal in granulosa cell function. Biol Reprod. 2002, 67 (6): 1653-1661. 10.1095/biolreprod.102.004952.PubMedView Article
  9. DeManno DA, Cottom JE, Kline MP, Peters CA, Maizels ET, Hunzicker-Dunn M: Follicle-stimulating hormone promotes histone H3 phosphorylation on serine-10. Mol Endocrinol. 1999, 13 (1): 91-105. 10.1210/me.13.1.91.PubMedView Article
  10. Salvador LM, Park Y, Cottom J, Maizels ET, Jones JC, Schillace RV, Carr DW, Cheung P, Allis CD, Jameson JL: Follicle-stimulating hormone stimulates protein kinase A-mediated histone H3 phosphorylation and acetylation leading to select gene activation in ovarian granulosa cells. J Biol Chem. 2001, 276 (43): 40146-40155.PubMedView Article
  11. Chen YJ, Hsiao PW, Lee MT, Mason JI, Ke FC, Hwang JJ: Interplay of PI3K and cAMP/PKA signaling, and rapamycin-hypersensitivity in TGFbeta1 enhancement of FSH-stimulated steroidogenesis in rat ovarian granulosa cells. J Endocrinol. 2007, 192 (2): 405-419. 10.1677/JOE-06-0076.PubMedView Article
  12. Yong EL, Turner M, Baird DT, Hillier SG: Molecular basis of gonadotrophin action on human granulosa cell function. Ann Acad Med Singapore. 1992, 21 (4): 510-516.PubMed
  13. Sasson R, Dantes A, Tajima K, Amsterdam A: Novel genes modulated by FSH in normal and immortalized FSH-responsive cells: new insights into the mechanism of FSH action. Faseb J. 2003, 17 (10): 1256-1266. 10.1096/fj.02-0740com.PubMedView Article
  14. Alliston TN, Maiyar AC, Buse P, Firestone GL, Richards JS: Follicle stimulating hormone-regulated expression of serum/glucocorticoid-inducible kinase in rat ovarian granulosa cells: a functional role for the Sp1 family in promoter activity. Mol Endocrinol. 1997, 11 (13): 1934-1949. 10.1210/me.11.13.1934.PubMedView Article
  15. Tajima K, Dantes A, Yao Z, Sorokina K, Kotsuji F, Seger R, Amsterdam A: Down-regulation of steroidogenic response to gonadotropins in human and rat preovulatory granulosa cells involves mitogen-activated protein kinase activation and modulation of DAX-1 and steroidogenic factor-1. J Clin Endocrinol Metab. 2003, 88 (5): 2288-2299. 10.1210/jc.2002-020913.PubMedView Article
  16. Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ: FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod. 2002, 8 (5): 426-433. 10.1093/molehr/8.5.426.PubMedView Article
  17. Alam H, Maizels ET, Park Y, Ghaey S, Feiger ZJ, Chandel NS, Hunzicker-Dunn M: Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem. 2004, 279 (19): 19431-19440. 10.1074/jbc.M401235200.PubMedPubMed CentralView Article
  18. Minegishi T, Kishi H, Tano M, Kameda T, Hirakawa T, Miyamoto K: Control of FSH receptor mRNA expression in rat granulosa cells by 3', 5'-cyclic adenosine monophosphate, activin, and follistatin. Mol Cell Endocrinol. 1999, 149 (1-2): 71-77. 10.1016/S0303-7207(98)00259-7.PubMedView Article
  19. Lin YF, Tseng MJ, Hsu HL, Wu YW, Lee YH, Tsai YH: A novel follicle-stimulating hormone-induced G alpha h/phospholipase C-delta1 signaling pathway mediating rat sertoli cell Ca2+-influx. Mol Endocrinol. 2006, 20 (10): 2514-2527. 10.1210/me.2005-0347.PubMedView Article
  20. Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D, Navarro JD, Mathivanan S, Pecquet C: NetPath: a public resource of curated signal transduction pathways. Genome Biol. 11 (1): R3-
  21. Oda K, Matsuoka Y, Funahashi A, Kitano H: A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol. 2005, 1: 2005.0010.
  22. Calzone L, Gelay A, Zinovyev A, Radvanyi F, Barillot E: A comprehensive modular map of molecular interactions in RB/E2F pathway. Mol Syst Biol. 2008, 4: 173-PubMedPubMed CentralView Article
  23. Oda K, Kitano H: A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol. 2006, 2: 2006.0015
  24. Le Novère N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM: The Systems Biology Graphical Notation. Mol Syst Biol. 2009, 27 (8): 735-41.
  25. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, Ceol A, Moore S, Orchard S, Sarkans U, von Mering C: The HUPO PSI's molecular interaction format--a community standard for the representation of protein interaction data. Nat Biotechnol. 2004, 22 (2): 177-183. 10.1038/nbt926.PubMedView Article
  26. Demir E, Cary MP, Paley S, Fukuda K, Lemer C, Vastrik I, Wu G, D'Eustachio P, Schaefer C, Luciano J: The BioPAX community standard for pathway data sharing. Nat Biotechnol. 28 (9): 935-942.
  27. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A: The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics. 2003, 19 (4): 524-531. 10.1093/bioinformatics/btg015.PubMedView Article
  28. Dilek A, Belviranli ME, Dogrusoz U: VISIBIOweb: visualization and layout services for BioPAX pathway models. Nucleic Acids Res. 38 (Suppl): W150-154.
  29. Babur O, Dogrusoz U, Demir E, Sander C: ChiBE: interactive visualization and manipulation of BioPAX pathway models. Bioinformatics. 26 (3): 429-431.
  30. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S: Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res. 2004, D497-501. 32 Database
  31. Hamosh A, Scott AF, Amberger J, Valle D, McKusick VA: Online Mendelian Inheritance in Man (OMIM). Hum Mutat. 2000, 15 (1): 57-61. 10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G.PubMedView Article
  32. Boeckmann B, Bairoch A, Apweiler R, Blatter MC, Estreicher A, Gasteiger E, Martin MJ, Michoud K, O'Donovan C, Phan I: The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003. Nucleic Acids Res. 2003, 31 (1): 365-370. 10.1093/nar/gkg095.PubMedPubMed CentralView Article

Copyright

© Pandey et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement